When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
Hosted on MSN19h
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoIts pipeline includes treatments for bipolar depression, agitation in Alzheimer’s disease, schizophrenia and Parkinson’s ...
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback